NEUROMEDICA, a clearinghouse for information concerning

the organic chemistry, design, and pharmacology of psychedelics and related compounds.

[ HOME | INTRODUCTION | CHEMISTRY | PHARMACOLOGY | PEOPLE | LINKS ]

Dr. Robert Oberlender, PhD.

 

Bibliography:

Oberlender R, 1995
Effect of a chiral 4-alkyl substituent in hallucinogenic amphetamines.
J. Med. Chem. 38, 3593-3601 (1995)

Pfaff RC, 1994
Lysergamides revisited.
NIDA Res. Monogr. 146, 52-73 (1994)

Oberlender R, 1992
Stereoselective LSD-like activity in d-lysergic acid amides of (R)- and
(S)-2-aminobutane.
J. Med. Chem. 35, 203-211 (1992)

Johnson MP, 1991
Synthesis and pharmacological examination of
1-(3-methoxy-4-methylphenyl)-2-aminopropane and
5-methoxy-6-methyl-2-aminoindan: similarities to
3,4-(methylenedioxy)methamphetamine (MDMA).
J. Med. Chem. 34, 1662-1668 (1991)

Oberlender R, 1991
Structural variation and (+)-amphetamine-like discriminative stimulus
properties.
Pharmacol. Biochem. Behav. 38, 581-586 (1991)

Nichols DE, 1991
2,3-Dihydrobenzofuran analogues of hallucinogenic phenethylamines.
J. Med. Chem. 34, 276-281 (1991)

Nichols DE, 1991
5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine.
Pharmacol. Biochem. Behav. 38, 135-139 (1991)

Oberlender R, 1990
(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative
stimulus in studies of 3,4-methylenedioxy-methamphetamine-like
behavioral activity.
J. Pharmacol. Exp. Ther. 255, 1098-1106 (1990)

Johnson MP, 1990
Behavioral, biochemical and neurotoxicological actions of the
alpha-ethyl homologue of p-chloroamphetamine.
Eur. J. Pharmacol. 191, 1-10 (1990)

Nichols DE, 1990
Nonneurotoxic tetralin and indan analogues of
3,4-(methylenedioxy)amphetamine (MDA).
J. Med. Chem. 33, 703-710 (1990)

Nichols DE, 1990
Structure-activity relationships of MDMA and related compounds: a new
class of psychoactive drugs?
Ann. N. Y. Acad. Sci. 600, 613-623 (1990)

Nichols DE, 1989
Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA)
analogues.
Pharmacol. Biochem. Behav. 34, 571-576 (1989)

Nichols DE, 1989
Structure-activity relationships of MDMA-like substances.
NIDA Res. Monogr. 94, 1-29 (1989)

Oberlender R, 1988
Drug discrimination studies with MDMA and amphetamine.
Psychopharmacology (Berl.) 95, 71-76 (1988)

Oberlender R, 1987
Tomoxetine and the stereoselectivity of drug action
J. Pharm. Pharmacol. 39, 1055-1056 (1987)

Nichols DE, 1986
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives
of a novel therapeutic class.
J. Med. Chem. 29, 2009-2015 (1986)

Nichols DE, 1986
Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the
hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug
discrimination studies in rats.
J. Med. Chem. 29, 302-304 (1986)

Nichols DE, 1984
Unreliability of the rat stomach fundus as a predictor of
hallucinogenic activity in substituted phenethylamines.
Life Sci. 35, 1343-1348 (1984)

Nichols DE, 1984
Synthesis and evaluation of substituted 2-phenylcyclobutylamines as
analogues of hallucinogenic phenethylamines: lack of LSD-like
biological activity.
J. Med. Chem. 27, 1108-1111 (1984)

Oberlender RA, 1984
Substituent branching in phenethylamine-type hallucinogens: a
comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and
1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane.
J. Med. Chem. 27, 788-792 (1984)

Nichols DE, 1984
Behavioral techniques in neuroreceptor research.
Monogr Neural Sci 10, 108-119 (1984)

 

[ HOME | INTRODUCTION | CHEMISTRY | PHARMACOLOGY | PEOPLE | LINKS ]

Created and maintained by paracelsus, with the cooperation of the Lycaeum.

Last updated on March 4, 1997.